Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 7 minute read Pharma Industry News Elanco (NYSE: ELAN) secures FDA EUA for Credelio in fight against New World screwworm in dogs Elanco’s Credelio receives FDA Emergency Use Authorization for screwworm treatment in dogs, positioning the company at the forefront of veterinary preparedness and parasite control. bySrinathOctober 25, 2025